Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
21 6月 2021
Regulatory reform for software-based consumer health - Can rules keep up with reality?
26 5月 2021
Australian Consumer Law marks 10 years with some large penalties
13 4月 2021
Pharmaceutical patent term extensions: federal court hears challenge to “absurd” Australian patent office ruling
11 3月 2021
A ‘new normal’ when it comes to the TGA regulation of medical devices?
8 3月 2021
Asia Pacific M&A Review 2021
26 2月 2021
Judicial review and the life sciences and health sectors
24 2月 2021
2020 Australian IPO Review: Key themes
24 2月 2021
2020 Australian IPO Review: IPOs by the numbers
16 2月 2021
Patent and Pharma update, February 2021
8 2月 2021
Healthcare as an Infrastructure asset
28 1月 2021
THE IMPACT OF THE NEW ITALIAN FOREIGN INVESTMENTS RULES ON THE PHARMA SECTOR
9 12月 2020
The arrival of the Omnibus
